Logo image of RDC.DE

REDCARE PHARMACY NV (RDC.DE) Stock Fundamental Analysis

FRA:RDC - NL0012044747 - Common Stock

72.5 EUR
-1.85 (-2.49%)
Last: 9/5/2025, 7:00:00 PM
Fundamental Rating

3

Overall RDC gets a fundamental rating of 3 out of 10. We evaluated RDC against 23 industry peers in the Consumer Staples Distribution & Retail industry. RDC scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. RDC is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

RDC had negative earnings in the past year.
In the past year RDC had a positive cash flow from operations.
RDC had negative earnings in each of the past 5 years.
RDC had a positive operating cash flow in 4 of the past 5 years.
RDC.DE Yearly Net Income VS EBIT VS OCF VS FCFRDC.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M

1.2 Ratios

RDC's Return On Assets of -2.81% is on the low side compared to the rest of the industry. RDC is outperformed by 77.27% of its industry peers.
The Return On Equity of RDC (-6.85%) is worse than 77.27% of its industry peers.
Industry RankSector Rank
ROA -2.81%
ROE -6.85%
ROIC N/A
ROA(3y)-5.45%
ROA(5y)-5.79%
ROE(3y)-11.19%
ROE(5y)-11.08%
ROIC(3y)N/A
ROIC(5y)N/A
RDC.DE Yearly ROA, ROE, ROICRDC.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -100 -200 -300 -400

1.3 Margins

RDC has a Gross Margin (23.16%) which is comparable to the rest of the industry.
RDC's Gross Margin has improved in the last couple of years.
The Profit Margin and Operating Margin are not available for RDC so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 23.16%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.88%
GM growth 5Y3.23%
RDC.DE Yearly Profit, Operating, Gross MarginsRDC.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20

5

2. Health

2.1 Basic Checks

RDC does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, RDC has less shares outstanding
The number of shares outstanding for RDC has been increased compared to 5 years ago.
RDC has a worse debt/assets ratio than last year.
RDC.DE Yearly Shares OutstandingRDC.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
RDC.DE Yearly Total Debt VS Total AssetsRDC.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

RDC has an Altman-Z score of 3.18. This indicates that RDC is financially healthy and has little risk of bankruptcy at the moment.
With a decent Altman-Z score value of 3.18, RDC is doing good in the industry, outperforming 63.64% of the companies in the same industry.
A Debt/Equity ratio of 0.61 indicates that RDC is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.61, RDC is in the better half of the industry, outperforming 77.27% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.61
Debt/FCF N/A
Altman-Z 3.18
ROIC/WACCN/A
WACC6.71%
RDC.DE Yearly LT Debt VS Equity VS FCFRDC.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M

2.3 Liquidity

RDC has a Current Ratio of 1.71. This is a normal value and indicates that RDC is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.71, RDC belongs to the top of the industry, outperforming 90.91% of the companies in the same industry.
A Quick Ratio of 1.29 indicates that RDC should not have too much problems paying its short term obligations.
RDC has a Quick ratio of 1.29. This is amongst the best in the industry. RDC outperforms 95.45% of its industry peers.
Industry RankSector Rank
Current Ratio 1.71
Quick Ratio 1.29
RDC.DE Yearly Current Assets VS Current LiabilitesRDC.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

6

3. Growth

3.1 Past

The earnings per share for RDC have decreased strongly by -201.31% in the last year.
Looking at the last year, RDC shows a very strong growth in Revenue. The Revenue has grown by 25.78%.
Measured over the past years, RDC shows a very strong growth in Revenue. The Revenue has been growing by 27.59% on average per year.
EPS 1Y (TTM)-201.31%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%319.05%
Revenue 1Y (TTM)25.78%
Revenue growth 3Y30.76%
Revenue growth 5Y27.59%
Sales Q2Q%26.49%

3.2 Future

RDC is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 52.57% yearly.
Based on estimates for the next years, RDC will show a quite strong growth in Revenue. The Revenue will grow by 18.77% on average per year.
EPS Next Y47.93%
EPS Next 2Y57.98%
EPS Next 3Y52.44%
EPS Next 5Y52.57%
Revenue Next Year25.66%
Revenue Next 2Y22.86%
Revenue Next 3Y21.31%
Revenue Next 5Y18.77%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
RDC.DE Yearly Revenue VS EstimatesRDC.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2B 4B 6B
RDC.DE Yearly EPS VS EstimatesRDC.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 5 10

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for RDC. In the last year negative earnings were reported.
RDC is valuated quite expensively with a Price/Forward Earnings ratio of 75.92.
Based on the Price/Forward Earnings ratio, RDC is valued more expensive than 86.36% of the companies in the same industry.
RDC is valuated expensively when we compare the Price/Forward Earnings ratio to 22.69, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 75.92
RDC.DE Price Earnings VS Forward Price EarningsRDC.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 -40 60

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, RDC is valued expensively inside the industry as 81.82% of the companies are valued cheaper.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 42.96
RDC.DE Per share dataRDC.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60 80 100

4.3 Compensation for Growth

RDC's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
RDC's earnings are expected to grow with 52.44% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y57.98%
EPS Next 3Y52.44%

0

5. Dividend

5.1 Amount

RDC does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

REDCARE PHARMACY NV

FRA:RDC (9/5/2025, 7:00:00 PM)

72.5

-1.85 (-2.49%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupConsumer Staples Distribution & Retail
GICS IndustryConsumer Staples Distribution & Retail
Earnings (Last)07-29 2025-07-29/bmo
Earnings (Next)10-29 2025-10-29
Inst Owners42.04%
Inst Owner ChangeN/A
Ins Owners7.4%
Ins Owner ChangeN/A
Market Cap1.47B
Analysts78.57
Price Target157.08 (116.66%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)170.32%
Min EPS beat(2)26.81%
Max EPS beat(2)313.82%
EPS beat(4)3
Avg EPS beat(4)86.3%
Min EPS beat(4)-42.68%
Max EPS beat(4)313.82%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-0.95%
Min Revenue beat(2)-1.13%
Max Revenue beat(2)-0.77%
Revenue beat(4)0
Avg Revenue beat(4)-1.35%
Min Revenue beat(4)-2.24%
Max Revenue beat(4)-0.77%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-6.71%
PT rev (3m)-8.79%
EPS NQ rev (1m)0%
EPS NQ rev (3m)N/A
EPS NY rev (1m)8.87%
EPS NY rev (3m)8.87%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.03%
Revenue NY rev (3m)0.17%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 75.92
P/S 0.55
P/FCF N/A
P/OCF 33.66
P/B 2.9
P/tB 14.17
EV/EBITDA 42.96
EPS(TTM)-1.74
EYN/A
EPS(NY)0.95
Fwd EY1.32%
FCF(TTM)-1.75
FCFYN/A
OCF(TTM)2.15
OCFY2.97%
SpS131.57
BVpS25.01
TBVpS5.12
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.81%
ROE -6.85%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 23.16%
FCFM N/A
ROA(3y)-5.45%
ROA(5y)-5.79%
ROE(3y)-11.19%
ROE(5y)-11.08%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.88%
GM growth 5Y3.23%
F-Score4
Asset Turnover2.15
Health
Industry RankSector Rank
Debt/Equity 0.61
Debt/FCF N/A
Debt/EBITDA 10
Cap/Depr 115.11%
Cap/Sales 2.96%
Interest Coverage N/A
Cash Conversion 142.36%
Profit Quality N/A
Current Ratio 1.71
Quick Ratio 1.29
Altman-Z 3.18
F-Score4
WACC6.71%
ROIC/WACCN/A
Cap/Depr(3y)87.99%
Cap/Depr(5y)151.24%
Cap/Sales(3y)2.78%
Cap/Sales(5y)3.59%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-201.31%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%319.05%
EPS Next Y47.93%
EPS Next 2Y57.98%
EPS Next 3Y52.44%
EPS Next 5Y52.57%
Revenue 1Y (TTM)25.78%
Revenue growth 3Y30.76%
Revenue growth 5Y27.59%
Sales Q2Q%26.49%
Revenue Next Year25.66%
Revenue Next 2Y22.86%
Revenue Next 3Y21.31%
Revenue Next 5Y18.77%
EBIT growth 1Y-216.55%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year306.71%
EBIT Next 3Y99.9%
EBIT Next 5Y68.62%
FCF growth 1Y-179.76%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y31.08%
OCF growth 3Y23.87%
OCF growth 5YN/A